Neuralink Corp. is a privately-held US brain computer interface (BCI) company developing an interface called “the Link”. The Link is inserted with the help of a robot into brain tissue. Then the hardware processes and transfer neural signals or brainwaves to operate a digital device.
Elon Musk has long-term goals for its technology like treating physical and mental health diseases and controlling digital devices with the brain. His more immediate goal is to help paralyzed people text without using their hands.
The company faces strong competitors in the brain implant industry especially Synchron, Precision Neuroscience, and Blackrock Neurotech. Neuralink has strong financial backing, and the company received FDA approval for human trials in May 2023.
The first time a Neuralink chip was implanted in a human brain was in January 2024. This first implantation was successful in that the patient was able use a computer as intended, but it malfunctioned with 85% of its implantation threads detaching from position which limited the device’s speed and efficacy.
The company’s second-ever patient will receive their implant June 2024, likely with implantation threads deeper into their brain to try to avoid another malfunction. Although over 1,000 quadriplegics have volunteered to be part of Neuralink’s study, Musk believes it will be at least a few more years before the general public will have access to Neuralink’s product. Experts at the National Institute for Health predict that Neuralink will need another decade to market "The Link" to the general public.
Direct transfers are allowed for existing investors only. New investors can get indirect exposure via special purpose vehicles or forward purchase contracts.
Neuralink’s stock climbed 9.27% year to date and 67.04% in the last 12 months. In the first quarter 2024, Neuralink was down -0.52% after rising 57.12% the quarter prior.
Last Updated June 21, 2024
Neuralink is a private venture-backed company that has issued 5 classes of preferred stock and 1 class of common stock. Neuralink has attracted $692.8M total funding since its incorporation. Neuralink’s most recent funding round totaling $43 million in November 2023. Neuralink’s largest round was its Series D which raised $281.5 million.
Type | Valuation | Date | PPS | Source |
---|---|---|---|---|
409-A |
Yes. Neuralink is a private venture-backed company. Investors usually purchase preferred stock and employees typically receive common stock options or restricted stock units (RSUs) as part of their compensation.
Since it is not publicly listed, there is no Neuralink stock symbol or Neuralink ticker symbol assigned for Neuralink.
Private companies typically reserve a stock symbol up to two years prior to an IPO, and disclose this when they file a Form S-1 with the Security Exchange Commission when they start the IPO process.
If you own shares of a private company, it may be possible to find liquidity for your holdings before the company goes public. Finding the right private market broker can make all the difference as the best brokers can leverage deep industry relationships and negotiate on your behalf.
If you are interested in selling private stock you can reach out to Premier brokers for more information.
Private market transactions can be complex and may involve company approvals, legal purchase agreements and wires to third parties. Trades can take 30 - 60 days to complete which is why many investors work with experienced private market brokers to help guide the process.
Direct share transfers typically require issuer approvals. Issuers may exercise the right of first refusal (ROFR) in order to direct the seller to a buyer of their choosing.
Some issuers do not allow transactions. In these cases, buyers will need to purchase indirect interests in the business via special purpose vehicles (SPVs) or forward purchase contracts (forwards).
Neuralink stock does not trade publicly on Nasdaq or NYSE because it is still a private company. Neuralink stock might be available for purchase in the secondary markets, but Neuralink stock is not available for purchase by the general public, and can not be purchased through traditional brokerage accounts.
Only accredited investors and qualified purchasers can buy private stock. These investors buy pre-IPO stock in the secondary market from existing employees and investors.
To learn more about the market for Neuralink stock, talk to the best brokers on the planet.
Accredited investors can purchase shares in private companies like Neuralink. Investors can rely on Notice Premier Brokers to find supply and guide them through the trading process.
Because Neuralink is privately held, its stock is not available for purchase through public stock exchanges like the NYSE or Nasdaq. Retail investors can not access this stock via traditional brokerage accounts, and are not allowed to invest directly in Neuralink pre-IPO.
Notice Price is algorithmically generated based on a number of inputs like private market activity, official company filings, internal marks, and comparables.
Developing accurate pricing for the private market, and making that pricing available to everyone has always been our mission.